Emimark 4mg Oral Drops
Manufacturer
R.T. Pharma
Salt Composition
Ondansetron (4mg)
Key Information
Short Description
Emimark 4mg Oral Drops is an antiemetic medicine commonly used to control nausea and vomiting due to certain medical conditions like stomach upset.
Dosage Form
Oral Drops
Introduction
Emimark 4mg Oral Drops may be used alone or with other medications and can be taken with or without food. Your doctor will suggest the appropriate dose depending on what you are taking it for. The first dose is normally taken before the start of surgery, chemotherapy, or radiotherapy. After these treatments, take any further doses as prescribed by your doctor (normally only for a few days at most). Take it regularly at the same time(s) each day to get the most benefit. Be careful not to take too much. This medicine does not relieve other side effects associated with cancer treatments. Also, it has little effect on vomiting caused by motion sickness. The most common side effects of taking this medicine include headache, diarrhea, or constipation and feeling tired. These symptoms should disappear when you stop taking the medicine. However, if these side effects bother you or do not go away, your doctor may be able to suggest ways of preventing or reducing them. Before taking this medicine, tell your doctor if you have heart or liver problems or a blockage in your stomach or intestines. Also, tell your doctor about any other medicines you might be taking, especially medicines to treat epilepsy, heart problems, cancer, and depression. These may affect or be affected by this medicine. If you are pregnant or breastfeeding, ask for advice from your doctor.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a marked dropper and take it as directed. Emimark 4mg Oral Drops may be taken with or without food but it is better to take it at a fixed time.
How it works
Emimark 4mg Oral Drops is an antiemetic medication. It works by blocking the action of a chemical messenger (serotonin) in the brain that may cause nausea and vomiting during anti-cancer treatment (chemotherapy) or after surgery.
Quick Tips
You have been prescribed Emimark 4mg Oral Drops for prevention of nausea and vomiting caused after surgery or due to chemotherapy and radiotherapy. It is fast-acting and starts working within 30 minutes. If you vomit within one hour of taking a dose, take another dose. Avoid heavy meals and try eating small nourishing snacks throughout the day. Also, sip water regularly to help avoid dehydration.
Related Medicines
Vomi X 4mg Oral Drops
Ondres 4mg Oral Drops
Nevervom 4mg Oral Drops
Kiaon 4mg Oral Drops
Ondica 4mg Oral Drops
Vomcet 4mg Oral Drops
Frequently asked questions
What is the onset of action of Emimark 4mg Oral Drops?
Emimark 4mg Oral Drops typically starts working within half an hour to 2 hours after administration, rapidly dissolving into the bloodstream and exerting its effect.
What are the common side effects of Emimark 4mg Oral Drops?
The most frequently reported side effects of Emimark 4mg Oral Drops include constipation, diarrhea, fatigue, and headache. These symptoms are usually mild and resolve on their own over time; however, it is essential to consult a doctor if they persist or cause concern.
How should Emimark 4mg Oral Drops be taken?
Emimark 4mg Oral Drops should be administered with a full glass of water, either before or after a meal. It is crucial to follow the dosage and treatment duration as prescribed by your doctor. Typically, the first dose of Emimark 4mg Oral Drops is given before surgery, chemotherapy, or radiation therapy.
Is Emimark 4mg Oral Drops a steroid?
No, Emimark 4mg Oral Drops is an antiemetic medication that functions as a selective 5-HT3 receptor antagonist. It is prescribed to prevent and treat nausea and vomiting associated with surgical procedures or cancer chemotherapy.
Is Emimark 4mg Oral Drops effective for motion sickness?
No, Emimark 4mg Oral Drops is not suitable for treating seasickness or motion sickness due to its limited effectiveness in addressing the type of nausea caused by such conditions.
